Peers of Sellas Life Sciences Group Inc (SLS)
Side-by-side comparison
Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
28.98x
As of Mar 30, 2023
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Mar 30, 2023 | 28.98x |
| Mar 29, 2023 | 26.25x |
| Mar 28, 2023 | 24.78x |
| Mar 27, 2023 | 25.20x |
| Mar 24, 2023 | 25.83x |
| Mar 23, 2023 | 25.62x |
| Mar 22, 2023 | 26.04x |
| Mar 21, 2023 | 27.30x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison